APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases

Opeyemi A. Olabisi,Jia-Yue Zhang,Lynn VerPlank,Nathan Zahler,Salvatore DiBartolo,John F. Heneghan,Johannes S. Schlöndorff,Jung Hee Suh,Paul Yan,Seth L. Alper,David J. Friedman,Martin R. Pollak

DOI: https://doi.org/10.1073/pnas.1522913113

IF: 11.1

2015-12-23

Proceedings of the National Academy of Sciences

Abstract:Significance People of recent African ancestry develop chronic kidney disease and end stage kidney failure at rates five times that of European-Americans. Two coding variants in the apolipoprotein-L1 (APOL1) gene account for nearly all this excess risk. The mechanisms by which APOL1 variants cause kidney failure are not understood. Recent evidence suggests that APOL1 transports cations, including K + , across lipid bilayers. Here, we show that tetracycline-induced expression of APOL1 kidney risk variants in T-REx-293 cells causes significant net efflux of intracellular K + , which, in turn, activates the stress-activated protein kinases (SAPKs) p38 MAPK and JNK, ultimately resulting in cytotoxicity. We propose that APOL1 nephropathy may be mediated by APOL1 risk variant-induced loss of intracellular K + and aberrant activation of SAPK signaling.

multidisciplinary sciences